No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT)

Aldo Sainato, Valentina Cernusco Luna Nunzia, Vincenzo Valentini, Antonino De Paoli, Enrici Riccardo Maurizi, Marco Lupattelli, Cynthia Aristei, Cristiana Vidali, Monica Conti, Alessandra Galardi, Pietro Ponticelli, Maria Luisa Friso, Tiziana Iannone, Falchetto Mattia Osti, Bruno Manfredi, Marianna Coppola, Cinzia Orlandini, Luca Cionini

Research output: Contribution to journalArticle

156 Citations (Scopus)

Abstract

To evaluate the effect of adjuvant chemotherapy (ACT) in locally advanced rectal cancer (LARC) after neoadjuvant chemoradiation (NACT-RT). The study was funded by the Italian National Research Council (CNR).
Original languageEnglish
Pages (from-to)223-229
Number of pages7
JournalRadiotherapy and Oncology
Volume113
DOIs
Publication statusPublished - 2014

Keywords

  • Adjuvant chemotherapy
  • Preoperative radiochemotherapy
  • Rectal cancer

Fingerprint

Dive into the research topics of 'No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT)'. Together they form a unique fingerprint.

Cite this